Mycinamicin is a 16-membered macrolide antibiotic produced by a “rare” actinomycete, Micromonospora griseorubida. Conditions for protoplasting of the mycelium of mycinamicin-producing M. griseorubida and regeneration of the protoplasts were established. A Micromonospora-E. coli shuttle cosmid vector, which was constructed from a cryptic plasmid of M. griseorubida and E. coli cosmid pJB8, was useful for manipulation of a long DNA sequence. The host vector system established in this way allowed to identify a gene (mycG) encoding a P-450-like protein probably responsible for both steps of hydroxylation and epoxidization of the lactone ring of mycinamicin. The mycG gene was located near myrB encoding a 23S rRNA methyltransferase as a self-resistance determinant and mycF encoding mycinamicin III O-methyltransferase. These studies will help to improve the mycinamicin productivity and to modify mycinamicin by genetic approaches.
No takes yet. Share an insight, caveat, or question.
Inouye et al. (1995) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: